1012 Priothera newco
BioCentury & Getty Images

Finance

Priothera raises €30 million to develop onetime Novartis candidate in AML transplantation setting

Start-up obtains S1PR modulator from Kyorin

By Paul Bonanos, Associate Editor

A VC syndicate is backing Priothera with a €30 million ($35.5 million) series A round to develop a clinical S1PR modulator for

Read the full 512 word article

How to gain access

Continue reading with a
two-week free trial.